Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis

Authors not listed

Universidade Federal Fluminense · 2024

Abstract

The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence(definition) in patients with chronic kidney disease (CKD) on hemodialysis (HD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2024). Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis. <em>Universidade Federal Fluminense</em>. https://clinicaltrials.gov/study/NCT06438445
Vancouver
Anonymous. Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis. Universidade Federal Fluminense. 2024.
BibTeX
@misc{anon2024Effect, title = {Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis}, author = {Anonymous}, journal = {Universidade Federal Fluminense}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings